Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | ARG1 | P05089 | 1/20 | 0.40 |
| ▸ | ARG2 | P78540 | 1/20 | 0.40 |
| ▸ | PAOX | Q6QHF9 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | PNP | P00491 | 1/20 | 0.33 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.32 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.32 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.32 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.32 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methacrylic Acid SCHEMBL43870 | 1.00 | CYP1A2 (0.44) | CYP1A2CYP2C9HPGDMAPK1HIF1A | |
| Diethylaminoethanol SCHEMBL11695020 | 0.96 | CYP1A2 (0.39) | CYP1A2CYP2C9HPGDMAPK1HIF1A | |
| Trolamine SCHEMBL44442 | 0.89 | MAPT (0.37) | CYP1A2CYP2C9HPGDMAPK1HIF1A | |
| Trolamine SCHEMBL345855 | 0.89 | MAPT (0.37) | CYP1A2CYP2C9HPGDMAPK1HIF1A | |
| Trolamine SCHEMBL43636 | 0.89 | MAPT (0.37) | CYP1A2CYP2C9HPGDMAPK1HIF1A | |
| Methacrylic Acid SCHEMBL9224280 | 0.88 | PAOX (0.40) | CYP1A2CYP2C9HPGDMAPK1HIF1A | |
| Acetic Acid SCHEMBL11209916 | 0.86 | CYP1A2 (0.50) | CYP1A2CYP2C9HPGDMAPK1HIF1A | |
| Methacrylic Acid SCHEMBL9222623 | 0.85 | CA12 (0.35) | CYP1A2CYP2C9HPGDMAPK1HIF1A | |
| Methacrylic Acid SCHEMBL1146682 | 0.84 | CHRM2 (0.38) | PAOXALDH1A1KDM4EMAPTCHRM2 | |
| Methacrylic Acid SCHEMBL11722830 | 0.83 | PAOX (0.43) | CYP1A2PAOXALDH1A1KDM4EMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024096019-A1 | DENTAL ADHESIVE COMPOSITION | クラレノリタケデンタル株式会社 | 2024-05-10 | — | — | WO | disclosed |
| EP-4364718-A1 | DENTAL CURABLE COMPOSITION | Kuraray Noritake Dental Inc. (JP) | 2024-05-08 | — | — | EP | disclosed |
| EP-2979679-B1 | CURABLE COMPOSITION FOR DENTAL USE | KURARAY NORITAKE DENTAL INC (JP) | 2023-11-29 | — | — | EP | disclosed |
| US-20230049373-A1 | PASTE-LIKE COMPOSITION FOR DENTAL USE, AND METHOD FOR PRODUCING THE SAME | KURARAY NORITAKE DENTAL INC. (JP) | 2023-02-16 | — | — | US | disclosed |
| US-11173100-B2 | Multi-part dental cement | KURARAY NORITAKE DENTAL INC. (JP) | 2021-11-16 | — | — | US | disclosed |
| EP-3530258-B1 | MULTI-PACK TYPE DENTAL CEMENT | KURARAY NORITAKE DENTAL INC (JP) | 2021-08-18 | — | — | EP | disclosed |
| US-20200155421-A1 | TWO-PASTE DENTAL CURABLE COMPOSITION | KURARAY NORITAKE DENTAL INC. (JP) | 2020-05-21 | — | — | US | disclosed |
| EP-3646847-A1 | TWO-PASTE TYPE DENTAL CURABLE COMPOSITION | Kuraray Noritake Dental Inc. (JP) | 2020-05-06 | — | — | EP | disclosed |
| EP-2226060-B1 | CEMENT FOR DENTAL APPLICATIONS | KURARAY NORITAKE DENTAL INC (JP) | 2020-03-04 | — | — | EP | disclosed |
| US-20190262240-A1 | MULTI-PART DENTAL CEMENT | KURARAY NORITAKE DENTAL INC. (JP) | 2019-08-29 | — | — | US | disclosed |
| EP-2979679-A1 | CURABLE COMPOSITION FOR DENTAL USE | Kuraray Noritake Dental Inc. (JP) | 2016-02-03 | — | — | EP | disclosed |
| US-9125802-B2 | Dental curable composition | KURARAY NORITAKE DENTAL INC. (JP) | 2015-09-08 | — | — | US | disclosed |
| EP-2656831-A1 | CURABLE DENTAL COMPOSITION | Kuraray Noritake Dental Inc. (JP) | 2013-10-30 | — | — | EP | disclosed |
| US-20130274426-A1 | DENTAL CURABLE COMPOSITION | KURARAY NORITAKE DENTAL INC. (JP) | 2013-10-17 | — | — | US | disclosed |
| US-8552088-B2 | Cement for dental applications | KURARAY NORITAKE DENTAL INC. (JP) | 2013-10-08 | — | — | US | disclosed |
| US-8545225-B2 | Redox-curing type composition | KURARAY NORITAKE DENTAL INC. (JP) | 2013-10-01 | — | — | US | disclosed |
| EP-2409997-A1 | REDOX-CURING TYPE COMPOSITION | Kuraray Medical Inc. (JP) | 2012-01-25 | — | — | EP | disclosed |
| US-20120016094-A1 | REDOX-CURING TYPE COMPOSITION | KURARAY MEDICAL INC. (JP) | 2012-01-19 | — | — | US | disclosed |
| US-20100267856-A1 | CEMENT FOR DENTAL APPLICATIONS | KURARAY MEDICAL INC. (JP) | 2010-10-21 | — | — | US | disclosed |
| EP-2226060-A1 | CEMENT FOR DENTAL APPLICATIONS | Kuraray Medical Inc. (JP) | 2010-09-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190262240-A1 | MULTI-PART DENTAL CEMENT | ASH2L, CAD, SETDB1 | CYP1A2 1043/4885CYP2C9 2722/4885HPGD 2284/4885 |
| US-11173100-B2 | Multi-part dental cement | ASH2L, CAD, SETDB1 | CYP1A2 1043/4885CYP2C9 2722/4885HPGD 2284/4885 |
| US-20130274426-A1 | DENTAL CURABLE COMPOSITION | BAZ2B, BRPF3, SHH | CYP1A2 1304/4885CYP2C9 1189/4885HPGD 1237/4885 |
| US-20200155421-A1 | TWO-PASTE DENTAL CURABLE COMPOSITION | CAD, DNMT3A, DNMT3B | CYP1A2 4354/4885CYP2C9 4230/4885HPGD 2624/4885 |
| US-20230049373-A1 | PASTE-LIKE COMPOSITION FOR DENTAL USE, AND METHOD FOR PRODUCING THE SAME | PFN1, XRN2, FLNA | CYP1A2 2947/4885CYP2C9 3238/4885HPGD 3548/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.